Intraepithelial lymphocytes vs. colorectal neoplastic cells: Who is winning the apoptotic battle?

Apoptosis

Volumn 2, Issue 6, 1997, Pages 489-493

  Rubio, C A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apoptosis; Colorectal adenomas; Intraepithelial lymphocytes

Indexed keywords

EID: 0001367353     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026430313275     Document Type: Review

References (42)

1. MacCarty WG. Principles of prognosis in cancer. JAMA 1931; 96: 30-33.
2. Beverly P. Tumor immunology. In: Roitt I, Brostoff J, Male D, eds. Immunology, Fourth Edition. London, UK: Mosby. 1996: 20.1-20.11.
3. Coca S, Perez-Piqueras J, Martinez D, et al. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 1997; 79: 2320-2328.
4. Jass JR. Lymphocytic infiltration and survival in rectal cancer. J Clin Pathol 1986; 39: 585-589.
5. Rubio CA, Kato Y, Hirota T. Intraepithelial lymphocytes in flat colorectal adenomas. In Vivo (1997, in press).
6. Svennevig JL, Lunde OC, Holter J, Björgsvik D. Lymphoid infiltration and prognosis in colorectal carcinoma. Br J Cancer 1984; 49: 375-377.
7. Yoong KF, Adams DH. Tumour infiltrating lymphocytes: insights into tumor immunology and potential therapeutic implications. J Clin Pathol Mol Pathol 1996; 49: 256-267.
8. Yoo YK, Heo DS, Hata K, van Thiel DH, Whiteside TL. Tumor infiltrating lymphocytes from human colonic carcinomas. Gastroenterology 1990; 98: 259-268.
9. Taunk J, Roberts AI, Ebert EC. Spontaneous cytotoxicity of human intraepithelial lymphocytes against epithelial cell tumors. Gastroenterology 1992; 102: 69-75.
10. Rubio CA, Söderberg G, Einhorn N. Histological and follow-up studies in cases of microinvasive carcinoma of the uterine cervix. Acta Pat Microbiol Scand 1974; 82: 397-410.
11. Lazenby AJ, Yardley JH, Giardello FM, Jessurum J, Bayless TM. Lymphocytic ('microscopic') colitis. Hum Pathol 1989; 20: 8-28.
12. Geboes K. Collagenous and microscopic colitis: clinical importance. Netherl J Med 1994; 45: 47-51.
13. Fisher ER, Sharkey DA. The ultrastructure of colonic polyps and cancer with special reference to the epithelial inclusion bodies of Leuchtenberger. Cancer 1962; 15: 160-170.
14. Walb D, Sandritter W. Inclusion bodies in rectal polyps. Arch Pathol 1964; 78: 104-107.
15. Wei YQ, Hang ZB, Liu KF. In situ observation of inflammatory tumor-cell interaction in human seminomas (germinomas). Hum Pathol 1992; 23: 421-428.
16. Wimmenauer S, Keller H, Rahner S, et al. Phenotypical and functional characteristics of tumor-infiltrating lymphocytes from colon carcinomas stimulated with rIL-2 and rIL-4 in vitro: comparison with lymphocytes of the normal colon mucosa and of peripheral blood. Anticancer Res 1994; 14: 963-968.
17. Balch CM, Riley LB, Bae YJ, et al. Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg 1990; 125: 200-205.
18. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-314.
19. Leuchtenberger C, Leuchtenberger R, Lieb E. Studies of the cytoplasmic inclusions containing desoxyribose nucleic acid (DNA) in human rectal polypoid tumors including familial hereditary type. Acta Genet 1956; 6: 291-297.
20. Leuchtenberger C. Cytoplasmic 'inclusion bodies' containing desoxyribose nucleic acid (DNA) in cells of human rectal polyps. Lab Invest 1954; 3: 132-142.
21. Rubio CA, Kumagai J, Kanamori T, Nakamura K. Apoptosis in flat neoplasias of the colorectal mucosa. In Vivo 1995; 9: 173-176.
22. Rubio CA, Alm T, Aly A, Poppen B. Intraepithelial bodies in colorectal adenomas: Leuchtenberger bodies revisited. Dis Colon Rectum 119; 34: 47-50.
23. Barth RJ, Camp B, Martuscello TA, Dain BJ, Memoli VA. The cytokine microenvironment of human colonic carcinoma. Cancer 1996; 78: 1168-1178.
24. Germain RN. MHC-dependant antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994; 76: 286-299.
25. Merogi AJ, Marrogi AJ, Ramesh R, Robinsson WR, Fermin CD, Freeman SM. Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas. Hum Pathol 1997; 28: 321-330.
26. O'Mahony AM, O'Sullivan GC, O'Connell J, Cotter TG, Collins JK. An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage. J Immunol 1993; 151: 4847-4856.
27. von Boehmer H. Positive selection of lymphocytes. Cell 1994; 76: 219-228.
28. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-1455.
29. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas-ligand apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189-1192.
30. O'Connell J, O'Sullivan GC, Collins JK. The Fas counter-attack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand J Exp Med 1996; 184: 1075-1082.
31. Hahne M, Rimoldi D, Scröter M, et al. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 1996; 274: 1363-1366.
32. Hardwick JM, Oyler GA, Clem RJ. AARC meeting on programmed cell death. Lake George, 19-23 October 1996. Apoptosis 1996; 1: 171-174.
33. Hayashi H, Tatebe S, Osaki M, Goto A, Susuki Y, Ito H. Expression of Fas antigen and its mediation of apoptosis in human gastric cancer cell lines. Jpn J Cancer Res 1997; 88: 49-55.
34. Niehans GA, Brunner T, Frizelle SP, et al. Human lung carcinomas express Fas ligand. Cancer Res 1997; 57: 1007-1012.
35. Rubio CA. Do tumor cells induce apoptosis in lymphocytes? Nature Med 1997; 3: 253-254.
36. Seino KI, Kayagaki N, Okumura K, Yagita H. Antitumor effect of locally produced CD95 ligand. Nature Med 1997; 3: 165-172.
37. Strand S, Hofmann WJ, Hug H, et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion? Nature Med 1996; 2: 1361-1366.
38. Uslu R, Jewett A, Bonavida B. Sensitization of human ovarian tumor cells by subtopic CDDP to anti-Fas antibody-mediated cytotoxicity and apoptosis. Gynecol Oncol 1996; 62: 282-291.
39. Rubio CA, Rodesnjö M. Flat adenomas and flat serrated adenomas of the colorectal mucosa: differences in the pattern of cell proliferation. Jpn J Cancer Res 1995; 86: 756-760.
40. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594-642.
41. Svendsen LB. Congenital genetic instability in colorectal carcinomas. Danish Med Bull 1993; 40: 546-556.
42. Koretz RL. Malignant polyps: are they sheep in wolves' clothing? Ann Int Med 1993; 118: 63-68.